Top Machine Learning Companies in Boston, MA (164)

Strong Revenue Growth: Recent results show total net revenue rising sharply—up 37% in 2025 and about 26% year over year in Q2 2026—while management described performance as reflecting solid top-line growth. Purchase volume also expanded materially, including a 27% increase in 2025 and strong gains into 2026.

Market Expansion: Scale expanded meaningfully with the May 2025 Discover acquisition, which added assets, deposits, loan portfolios, and payment-network capabilities. As of early 2026, reported assets of about $683 billion and deposits near $489 billion underscore the larger combined footprint, and external commentary anticipates further expansion.

Strong Market Position & Advantage: The company is identified as the largest U.S. credit-card issuer by outstanding balances as of year-end 2025 and one of the nation’s largest banks by deposits, with customer-satisfaction leadership among national banks. The addition of Discover’s network further reinforces a differentiated competitive position.

Product Line Growth: The product footprint is expanding, with S&P highlighting Kensho Link and the LLM‑ready API while Kensho adds datasets like private‑company financials and Capital IQ Estimates plus integrations with Anthropic, ChatGPT, Amazon Quick Suite, and Databricks. This indicates broader functionality and distribution across enterprise AI workflows.

Strategic Partnerships: Enterprise collaborations are scaling, exemplified by RBC Capital Markets integrating Kensho/S&P Global data to 8,000 employees and reported ties into ecosystems such as Cohere and MCP-enabled chat interfaces. These relationships suggest growing commercial reach through key institutional channels.

Future-Ready Strategy: S&P Global’s July 2026 reorganization established Kensho Data & Platforms as the client-facing data-product and AI-delivery layer, positioning the business to accelerate AI-powered products. This structural elevation signals commitment to AI-led growth across S&P’s portfolio.

Strong Revenue Growth: Company disclosures indicate robust year-over-year ARR expansion in the latest period, accompanied by rising large-contract customer counts and broader multi‑product uptake. Feedback suggests enterprise standardization is reinforcing this top‑line momentum.

Market Expansion: International business is scaling across APAC and EMEA, while the customer mix includes numerous Fortune 500 and Global 2000 organizations standardizing on the platform. Cross‑sell gains and broader regional presence point to a widening commercial footprint.

Innovation-Driven Growth: Rapid adoption of newer AI and agentic testing capabilities, alongside increased API and mobile testing usage, signals product‑led expansion. Feedback suggests these innovations are catalyzing deeper engagement across the unified platform.

Investor Backing & Capital Strength: Significant financing includes a $56.1M Series C in 2024 and additional growth-capital funding from CIBC Innovation Banking in March 2026, signaling continued investor confidence and runway. Company communications indicate these funds are directed toward product development, R&D, customer success, and sales.

Product Line Growth: Recent launches and expansions span Renewal Analytics, workers’ compensation capabilities (including a claims-triage solution), and a major expansion of the Group Health analytics platform, alongside an integrated Risk Management Life Cycle solution. This pattern points to broadening coverage across underwriting, renewals, and claims.

Customer Loyalty & Retention: Current materials highlight hundreds of enterprise deployments with very high client retention, paired with ongoing wins and deployments in 2025–26 (e.g., Community Health Options, Evolution Risk Partners, and continued 2026 additions). These signals suggest a sticky and expanding customer base.

Strong Revenue Growth: ARR is reported to have surpassed $200M by June 2026 after crossing $100M in early 2025, with five consecutive years of 100% year-over-year growth. This consistent doubling signals rapid scaling at substantial revenue levels.

Investor Backing & Capital Strength: Funding rounds include $75M in 2024 at a valuation above $1B and a $250M Series E in 2025 at a reported $2.2B, with total capital raised cited at $400M+. Such late-stage financing and rising valuations indicate robust access to growth capital.

Strong Market Position & Advantage: Adoption is described as reaching roughly 1 in 6 U.S. apartments, with deep penetration among large property managers and hundreds of operators. Expansion into healthcare and notable distribution relationships have broadened its commercial footprint.

Strong Revenue Growth: Revenue has scaled materially, with ARR approaching the $400M mark and leadership targeting expansion toward $1B, alongside earlier signals such as 42% YoY ARR growth and very high renewal/net expansion. Feedback suggests recent indications of ~$300–350M revenue and expanding customer/end‑user coverage reinforce continued momentum.

Investor Backing & Capital Strength: A majority investment by Vista Equity Partners at an approximately $3B valuation signals strong capital support and confidence in the company’s scaling prospects. Feedback suggests this backing, including associated financing, enables continued product and geographic expansion.

Strong Market Position & Advantage: Repeated recognition as a Leader in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s EUEM Wave points to sustained category leadership. Large‑scale enterprise adoption (e.g., 1,500+ customers and 25M+ employees served) further entrenches competitive positioning.

Market Expansion: The company added Arlington, VA (2024) and Seattle, WA (2025) to its Cambridge base, explicitly linking the Seattle opening to “steady growth” and proximity to customers and talent. This footprint expansion indicates broader geographic reach and increased customer access.

Innovation-Driven Growth: Large awards tied to advanced technologies—such as a ~$97.5M Army STEAM IDIQ for AI-enabled systems, a $48M Army UAS OTA, and a DARPA Albatross prime—show momentum in AI/ML, autonomy, and high-end R&D. These programs suggest growing demand for its applied engineering and experimentation capabilities.

Strong Hiring & Retention: Headcount signals moved from 150+ employees in 2022 to roughly 200+ more recently, alongside active multi-site recruiting. Workplace recognitions and the company’s description as a “thriving” employee-owned firm support continued talent attraction.

Profitability: The company is described as privately held, profitable, and debt-free, indicating a solid financial base. This positioning supports continued investment without reliance on external financing.

Strong Revenue Growth: Revenue is reported above $1 billion with indications of year-over-year increases into 2024 and sustained scale into FY2025, while cloud segments are noted as expanding strongly. These signals point to ongoing top-line momentum.

Market Expansion: Operations span 28 countries with 38 offices serving customers in 80+ countries, alongside recent moves such as a dedicated public-sector subsidiary and added international presence. This footprint suggests continued geographic and channel growth.

Market Expansion: ASI has broadened beyond commercial aviation into defense and critical infrastructure, adding a DIU sustainment tool, a National Grid collaboration, and a Joby partnership alongside a major FAA program rolling out from the Washington, D.C. region. Company materials describe a scope spanning aviation, defense, logistics, energy and more, with locations in Boston, Washington, D.C., and Gdańsk.

Strong Market Position & Advantage: A 12-year, $875M FAA selection for FMDS and SMART—now in operational deployment around Washington, D.C.—signals meaningful competitive strength at national scale. Available reporting indicates ASI prevailed in a field that included larger incumbents, underscoring differentiation.

Strong Hiring & Retention: Signals include a “rapidly expanding team,” added offices, and recent defense-oriented roles (e.g., a Data Lead in Colorado Springs), with external coverage citing 165+ employees and plans to grow beyond 250 to deliver major programs. Active postings across technical and federal roles further reflect continued team build-out.

Strong Revenue Growth: ARR moved from surpassing $300M in June 2025 to exceeding $400M by May 2026, indicating a substantial year-over-year increase. The company also reported a 36% five-year organic CAGR in 2024, underscoring sustained momentum.

Product Line Growth: Edwin AI recurring revenue is reported to be growing around 200% year over year and contributing about one-third of total bookings. The December 2025 Catchpoint acquisition expanded capabilities into internet performance and digital experience monitoring.

Market Expansion: Larger enterprise accounts grew more than 25% year over year in 2025 and the company cited 700+ enterprise customers by late 2025. More than 30% of new customers came from outside the U.S., indicating ongoing international expansion.

Strong Revenue Growth: Company reports indicate FY2026 orders and revenue doubled year over year. Management projections point to revenue well above $500 million for 2026, signaling rapid topline acceleration.

Investor Backing & Capital Strength: Recent financings include a $1.5 billion Series G and $500 million in preferred equity at a $12.7 billion valuation. These steps indicate substantial capital access and confidence from major financial backers.

Market Expansion: Program momentum includes a U.S. Air Force production award for CCA autonomy and a U.S. Navy ISR vehicle with a high task‑order ceiling. International traction spans India, Greece, Poland, and Taiwan, alongside plans for regional offices.

Investor Backing & Capital Strength: Funding reached a $200M Series C in July 2024 at a $1B valuation with prominent investors. Available evidence suggests substantial capital to scale and strong external confidence.

Market Expansion: Engagements extended across governments and enterprises, including the UK’s £8M three-year program, a CBP contract expansion, and new deployments with General Atomics Aeronautical Systems and Scarbrough Global; by 2026, the company said 8 of the world’s 10 largest logistics providers were customers. These signals indicate continued penetration into large, international accounts and public-sector programs.

Product Line Growth: The offering broadened beyond supply-chain mapping into compliance, procurement, trade-risk management, and customs-automation workflows, including the 2026 Cervo AI acquisition. 2025–2026 materials describe additional use cases and live customer deployments.

Strong Revenue Growth: Recent results indicate total revenue increased year over year in 2025 and continued to rise in the latest reported quarter. Guidance and quarterly updates point to ongoing top-line expansion even as mix shifts occur.

Resilient & Sustainable Growth: Underlying annual contract value expanded and accelerated in 2026, with management indicating continued growth despite the transition to hosted licensing. This suggests the core subscription base is strengthening even when reported revenue timing varies.

Diversified Revenue Streams: Growth is visible in both the software business and the milestone-driven drug discovery segment. The latter stepped up meaningfully in recent periods, complementing steady software momentum.

Strong Revenue Growth: Subscription revenue is described as growing at a double‑digit year‑over‑year pace as of late 2023, signaling solid momentum in the core recurring model.

Customer Loyalty & Retention: Renewal rates are reported as extremely high, indicating sticky relationships and a durable subscription base.

Market Expansion: The underlying hotel‑data network has expanded materially to a larger global sample across nearly 200 countries, pointing to broader reach and scale.

Strong Revenue Growth: Revenue is rising at double-digit rates across recent periods, and management has increased full-year guidance, underscoring continued momentum. Growth is visible in both recent quarters and the prior year, indicating sustained top-line expansion.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with data-licensing/Insights activity increasing alongside clinical testing volumes. This mix reduces reliance on a single line of business and supports multiple growth vectors.

Strategic Partnerships: Collaborations with major biopharmaceutical companies and broader rollouts of platforms such as Next signal expanding commercial reach. Announced initiatives like a large whole‑genome dataset and work with firms including Merck reinforce external demand for the platform.

Strategic Partnerships: The company has formed high-profile alliances with Google Cloud, Wolters Kluwer, Endeavor Health, Carle Health, and Integrated Physician Network to scale value-based care and its AI platform. These collaborations are positioned to accelerate provider-partnership expansion and market reach across multiple regions.

Innovation-Driven Growth: The launch of Tom, an AI-powered Primary Care as a Service platform, and its integration with evidence-based clinical content signal a strong technology engine for growth. Emphasis on AI to expand capacity, reduce administrative burden, and improve access supports outcomes-focused scaling.

Strong Revenue Growth: The business reported $3 billion in 2024 revenue with substantial year-over-year growth. Scale signals include managing billions in medical spend and expanding its Medicare Advantage footprint into additional states and markets.